Just leaving this here for the uninitiated:
This is how the patients who's time on MPL we know (from the NFL interim data release 22/08) look using the 10.6 month average (leaving the 13 months out as we don't know which patients are which):
First dose of MPL after diagnosis (days): Duration of treatment
(Average: 10.6 months x 30.4 days which is the average days in a month)Total time since diagnosis: Years since diagnosis 1 A 377 322 699 1.92 2 B 323 322 645 1.77 3 C 480 322 802 2.20 4 D 668 322 990 2.71 5 E 432 322 754 2.07
The 13 month patients are even more impressive.
Obviously the above is just a small snapshot until the full data is released, but the fact that all patients are still not only alive, but still breathing and swallowing unassisted is fantastic news for everyone involved.
That top-line data can't come fast enough.
- Forums
- ASX - By Stock
- Ann: PAA completes Phase 1 and files for Orphan Drug Designation
Just leaving this here for the uninitiated: This is how the...
- There are more pages in this discussion • 421 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAA (ASX) to my watchlist
(20min delay)
|
|||||
Last
24.5¢ |
Change
0.005(2.08%) |
Mkt cap ! $96.77M |
Open | High | Low | Value | Volume |
24.0¢ | 24.5¢ | 24.0¢ | $47.37K | 197.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 10000 | 24.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
24.5¢ | 27970 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 10000 | 0.240 |
5 | 45225 | 0.235 |
9 | 50500 | 0.230 |
5 | 150174 | 0.225 |
3 | 140455 | 0.220 |
Price($) | Vol. | No. |
---|---|---|
0.245 | 27970 | 3 |
0.250 | 198044 | 4 |
0.255 | 85000 | 3 |
0.260 | 90000 | 2 |
0.265 | 111500 | 2 |
Last trade - 16.10pm 29/04/2024 (20 minute delay) ? |
|
|||||
Last
24.5¢ |
  |
Change
0.005 ( 2.77 %) |
|||
Open | High | Low | Volume | ||
24.5¢ | 24.5¢ | 24.0¢ | 93977 | ||
Last updated 15.00pm 29/04/2024 ? |
Featured News
PAA (ASX) Chart |